AllesG. A.HawesR. C. (1940). Cholinesterases in the blood of man. Journal of Biological Chemistry, 133, 375–390.
2.
AmmonR. (1933). Die Fermentative Spaltung des Acetylcholins. Archiv für die gesamte Physiologie des Menschen und der Tiere, 233, 486–491.
3.
AugustinssonK. B. (1948). Cholinesterases: A study in comparative enzymology. Acta Physiologica Scandinavica, 15, Supplement 52, 1–182.
4.
AugustinssonK. B. (1955a). A titimetric method for the determination of plasma and red blood cell cholinesterase activity using thiocholine esters as substrates. Scandinavian Journal of Clinical and Laboratory Investigation, 7, 284–290.
5.
AugustinssonK. B. (1955b). The normal variation of human blood cholinesterase activity. Acta Physiologica Scandinavica, 35, 40–52.
6.
AugustinssonK. B. (1971). Determination of activity of cholinesterases. In Analysis of Biogenic Amines and their Related Enzymes, edited by GlickD., pp. 217–273. Interscience Press, New York.
7.
BannisterJ.WhittakerV. P.WijesunderaS. (1951). The occurrence of homologues of acetylcholine in ox spleen. Journal of Physiology, 115, 55–71.
8.
BauldH. W.GibsonP. F.JebsonP. J.BrownS. S. (1974). Aetiology of prolonged apnoea after suxamethonium. British Journal of Anaesthesia, 46, 273–281.
9.
BiggsH. G.CareyS.MorrisonD. B. (1958). Simple colorimetric method for measuring activities of cellular and plasma cholinesterase. American Journal of Clinical Pathology, 30, 181–186.
10.
BirksD. A.PriorV. J.SilkE.WhittakerM. (1968). Ecothiopate Iodide treatment of glaucoma in pregnancy. Archives of Ophthalmology, 79, 283–285.
11.
BourneJ. G.CollierH. O.SomersG. F. (1952). Succinylcholine (succinoylcholine): muscle relaxant of short action. Lancet, 1, 1225–1229.
12.
BovetD.Bovet-NittiF.GuarinoS.LongoV. G.MarottaM. (1949). Proprieta farmacodinamiche di al curi derivati della succinilcolina dolati di azione curarica. Rendiconti Istituto Superiore di Sanita, Roma, 12, 106; quoted in Biological Abstracts, 24, 3276–3283.
13.
British Journal of Anaesthesia (1967). Editorial. Suxamethonium apnoea. British Journal of Anaesthesia, 39, 837.
14.
BushG. H. (1961). Prolonged apnoea due to suxamethonium. British Journal of Anaesthesia, 33, 454–462.
15.
CarawayW. T. (1956). Photometric determination of serum cholinesterase activity. American Journal of Clinical Pathology, 26, 945–955.
16.
ClitherowJ. W.MitchardM.HarperN. J. (1963). The possible biological function of pseudocholinesterase. Nature, 199, 1000–1001.
17.
CourvilleD. A.LedingtonW. (1951). A new method of assay for serum esterase. Journal of Biological Chemistry, 190, 575–584.
18.
DaleH. H. (1914). The action of certain esters and ethers of choline and their relation to muscarine. Journal of Pharmacology and Experimental Therapeutics, 6, 147–190.
19.
DaviesR. D.MortonA. V.KalowW. (1960). The action of normal and atypical cholinesterase of human serum upon a series of esters of choline. Canadian Journal of Biochemistry, 38, 545–551.
20.
De La HuergaJ.YesinickC.PopperH. (1952). Colorimetric method for the determination of serum cholinesterase. American Journal of Clinical Pathology, 22, 1126–1133.
EllisF. R.CainP. A.HarrimanD. G. F.ToothillC. (1978). Plasma cholinesterase and malignant hyperpyrexia (Letter). British Journal of Anaesthesia, 50, 86.
23.
EllmanG. L. (1959). Tissue sulfhydryl groups. Archives of Biochemistry and Biophysics, 82, 70–77.
24.
EllmanG. L.CourtneyK. D.AndresV.FeatherstoneR. M. (1961). A new and rapid colorimetric determination of acetylcholinesterase. Biochemical Pharmacology, 7, 88–95.
25.
EngelhardtE.LoewiE. (1930). Fermentative azetylcholinspaltung im blut und ihre hemmung durch physostigmin. Archiv für experimentelle Pathologie und Pharmakologie, 150, 1–13.
EvansF. T.GrayP. W. S.LehmannH.SilkE. (1952). Sensitivity to succinylcholine in relation to serum cholinesterase. Lancet, 1, 1229–1230.
28.
EvansF. T.GrayP. W. S.LehmannH.SilkE. (1953). Effect of pseudocholinesterase level on action of succinylcholine in man. British Medical Journal, 1, 136–138.
29.
FeldbergW. (1951). The physiology of neuromuscular transmission and neuromuscular block. British Medical Journal, 1, 967–976.
30.
ForbatA.LehmannH.SilkE. (1953). Prolonged apnoea following injection of succinylcholine. Lancet, 2, 1067–1068.
31.
GalE. M.RothE. (1957). Spectrophotometric methods for determination of cholinesterase activity. Clinica Chimica Acta, 2, 316–326.
32.
GarryP. J. (1971). Serum cholinesterase variants: examination of several differential inhibitors, salts and buffers used to measure enzyme activity. Clinical Chemistry, 17, 183–191.
33.
GarryP. J.RouthJ. I. (1965). A micromethod for serum cholinesterase. Clinical Chemistry, 11, 91–96.
34.
GlickD. (1938). Studies on the specificity of cholinesterase. Journal of Biological Chemistry, 125, 729–739.
35.
GoeddeH. W.BaitschH. (1964). On nomenclature of pseudocholinesterase polymorphism. Acta Genetica et Statistica Medica, 14, 366–369.
36.
GoeddeH. W.GehringD.HoffmanR. A. (1965). On the problem of the ‘silent gene’ in pseudocholinesterase polymorphism. Biochimica et Biophysica Acta, 107, 391.
37.
HarrisH.HopkinsonD. A.RobsonE. B. (1962). Two-dimensional components in normal human serum. Nature, 196, 1296–1298.
38.
HarrisH.HopkinsonD. A.RobsonE. B.WhittakerM. (1963). Genetical studies on a new variant of serum cholinesterase detected by electrophoresis. Annals of Human Genetics, 26, 359–382.
39.
HarrisH.WhittakerM. (1961). Differential inhibition of human serum cholinesterase with fluoride: recognition of two new phenotypes. Nature, 191, 496–498.
40.
HarrisH.WhittakerM. (1962). The serum cholinesterase variants. A study of twenty-two families selected via the intermediate phenotype. Annals of Human Genetics, 26, 59–72.
41.
HarrisH.WhittakerM. (1963). Differential inhibition of ‘usual’ and ‘atypical’ serum cholinesterase by NaCl and NaF. Annals of Human Genetics, 27, 53–58.
42.
HarrisH.WhittakerM.LehmannH.SilkE. (1960). The cholinesterase variants. Esterase levels and dibucaine numbers in families selected through suxamethonium sensitive individuals. Acta Genetica et Statistica Medica, 10, 1–16.
43.
HodgkinW. E.GiblettE. R.LevineH.BaurW.MotulskyA. G. (1965). Complete pseudocholinesterase deficiency: genetic and immunological considerations. Journal of Clinical Investigation, 44, 486–493.
44.
HolmstedtB.SjöquistF. (1960). Pharmacological properties of γ-aminobutyryl-choline. A supposed inhibitory neurotransmitter. Biochemical Pharmacology, 3, 297–304.
45.
HuntA. H.LehmannH. (1960). Serum albumin pseudocholinesterase and transaminase in the assessment of liver function before and after venous shunt operations. Gut, 1, 303–311.
46.
HuntR.de TaveauxR. M. (1906). On the physiological action of certain choline derivatives and new methods of detecting choline. British Medical Journal, 2, 1788–1791.
47.
International Union of Biochemistry (1961). Report of the Commission on Enzymes. Pergamon Press, London.
48.
International Union of Biochemistry (1972). The nomenclature of multiple forms of enzymes. Biochemical Journal, 126, 769–771.
49.
JamiesonD. (1963). The function of true and pseudocholinesterase in the mammalian ilium. Biochemical Pharmacology, 12, 693–703.
50.
JørgensenK. (1959). Automatic recording of cholinesterase activities. Scandinavian Journal of Clinical and Laboratory Investigation, 11, 282–284.
51.
KalowW. (1952). Hydrolysis of local anaesthetics by human serum cholinesterase. Journal of Pharmacology and Experimental Therapeutics, 104, 122–134.
52.
KalowW. (1959). Cholinesterase Types. In Biochemistry of Human Genetics, edited by WolstenholmeG. E. W.O'ConnorC. M., pp. 39–59. Churchill, London.
53.
KalowW. (1964). The influence of pH on the hydrolysis of benzoylcholine by pseudocholinesterase of human plasma. Canadian Journal of Physiology and Pharmacology, 42, 161–168.
54.
KalowW. (1965). Contribution of hereditary factors to the response to drugs. Federation Proceedings, 24, 1259–1265.
55.
KalowW.DaviesR. O. (1958). The activity of various esterase inhibitors towards atypical human serum cholinesterase. Biochemical Pharmacology, 1, 183–192.
56.
KalowW.GenestK. (1957). A method for the detection of atypical forms of human serum cholinesterase. Determination of dibucaine numbers. Canadian Journal of Biochemistry, 35, 339–346.
57.
KalowW.LindsayH. A. (1955). A comparison of optical and manometric methods for the assay of human serum cholinesterase. Canadian Journal of Biochemistry, 33, 568–574.
58.
KalowW.StaronN. (1957). On distribution and inheritance of atypical forms of human serum cholinesterase as indicated by dibucaine numbers. Canadian Journal of Biochemistry, 35, 1305–1320.
59.
KingJ. (1974). Studies on human cholinesterase. Ph.D. Thesis, University of Glasgow.
60.
KingJ.DixonR. I. (1969). A further factor contributing to inherited suxamethonium sensitivity. British Journal of Anaesthesia, 41, 1023–1028.
61.
KingJ.GriffinD. (1974). Relationship between suxamethonium apnoea, serum cholinesterase activity and inhibitor numbers. British Journal of Anaesthesia, 46, 908–911.
62.
KingJ.McQueenM. J.MorganH. G. (1971). The effect of temperature on fluoride-resistant serum cholinesterase. British Journal of Anaesthesia, 43, 669–672.
63.
KingJ.MorganH. G. (1970). The temperature activity relationships of serum cholinesterase. Journal of Clinical Pathology, 23, 730–732.
64.
KingJ.RitchieG. (1973). Screening procedures for serum cholinesterase (CHE) variants. Proceedings of the 5th International Symposium on Clinical Enzymology, 2, 347–358.
65.
KoelleG. B. (1963). Cytological distributions and physiological functions of cholinesterases. In Cholinesterases and Anticholinesterase Agents, edited by KoelleG. B., pp. 187–298. Springer Verlag, Berlin.
66.
KramerD. N.GanesonR. M. (1958). Colorimetric determination of acetylcholinesterase activity. Analytical Chemistry, 30, 251–253.
67.
LehmannH.LiddellJ. (1969). Human cholinesterase (pseudocholinesterase): genetic variants and their recognition. British Journal of Anaesthesia, 41, 235–244.
68.
LehmannH.PatstonV.RyanE. (1958). The inheritance of an idiopathic low pseudocholinesterase level (Letter). Journal of Clinical Pathology, 11, 554.
69.
LehmannH.RyanE. (1956). The familial incidence of low pseudocholinesterase level (Letter). Lancet, 2, 124.
70.
LehmannH.SilkE. (1953). Succinylmonocholine. British Medical Journal, 1, 767–768.
71.
LehmannH.SilkE.HarrisH.WhittakerM. (1960). A new pseudocholinesterase phenotype?Acta Genetica et Statistica Medica, 10, 241–246.
72.
LiddellJ.LehmannH.DaviesD.SharihA. (1962a). Physical separation of pseudocholinesterase variants in human serum. Lancet, 1, 463–464.
73.
LiddellJ.LehmannH.SilkE. (1962b). A ‘silent’ pseudocholinesterase gene. Nature, 193, 561–562.
74.
LiddellJ.NewmanG. E.BrownD. F. (1963). A pseudocholinesterase variant in human tissues. Nature, 198, 1090–1091.
75.
LoewiO. (1921). Über humorale übertragbarkeit der herznervenwirkung. Pflügers Archiv für die gesamte Physiologie des Menschen und der Tiere, 189, 239–242.
76.
LoewiO.NavratilE. (1921). Über humorale übertragbarkeit der herznervenwirkung XI. Über den mechanismus du vaguswirkung von physostigmin und ergotamin. Pflügers Archiv für die gesamte Physiologie des Menschen und der Tiere, 214, 689–696.
77.
McArdleB. (1940). The serum cholinesterase in jaundice and diseases of the liver. Quarterly Journal of Medicine, 9, 107–119.
78.
McCombR. B.La MottaR. V.WetstoneH. J. (1965). Procedure for detecting atypical serum cholinesterase using o-nitrophenylbutvrate as substrate. Clinical Chemistry, 11, 645–652.
79.
McOskerD. E.DanielL. J. (1959). A colorimetric micromethod for the determination of cholinesterase. Archives of Biochemistry and Biophysics, 79, 1–7.
80.
MainA. R.MilesK. E.BraidP. E. (1961). The determination of human serum cholinesterase activity with o-nitrophenylbutyrate. Biochemical Journal, 78, 769–776.
81.
MendelB.MundellD. B. (1943). Studies on cholinesterase, II. A method for the purification of a pseudocholinesterase from dog pancreas. Biochemical Journal, 37, 64–66.
82.
MendelB.MundellD. B.RudneyH. (1943). Studies on cholinesterase, III. Specific tests for true cholinesterase and pseudocholinesterase. Biochemical Journal, 37, 473–476.
83.
MendelB.RudneyH. (1943). Studies on cholinesterase, I. Cholinesterase and pseudocholinesterase. Biochemical Journal, 37, 59–63.
84.
MendelB.RudneyH. (1945). Some effects of salts on true cholinesterase. Science, 102, 616–617.
85.
MichelH. O. (1949). Electrometric method for determination of red blood cell and plasma cholinesterase activity. Journal of Laboratory and Clinical Medicine, 34, 1564–1568.
86.
MolanderD. W.FriedmanM. M.La DueJ. S. (1954). Serum cholinesterase in hepatic and neoplastic diseases: a preliminary report. Annals of Internal Medicine, 41, 1139–1151.
87.
MotulskyA. G. (1964). Pharmacogenetics. In Progress in Medical Genetics, Volume III, edited by SteinbergA. G.BearnA. G.Grune and Stratton, New York.
88.
NabbD. P.WhitfieldF. (1967). Determination of cholinesterase by an automated pH stat method. Archives of Environmental Health, 15, 147.
89.
NachmansohnD.HestrinS.VoripaieffH. (1949). Enzymatic synthesis of a compound with acetycholine-like biological activity. Journal of Biological Chemistry, 180, 875–877.
90.
NambaT.HirakiK. (1958). PAM (pyridine-2-aldoxime methiodide) therapy for alkylphosphate poisoning. Journal of the American Medical Association, 166, 1834–1839.
91.
OrdM. G.ThompsonR. H. S. (1952). Pseudocholinesterase activity in the central nervous system. Biochemical Journal, 51, 245–251.
92.
RappaportF.FishlL.PintoN. (1959). Improved method for estimation of cholinesterase activity in serum. Clinica Chimica Acta, 4, 227–230.
93.
RavinH. A.TsouK. C.SeligmanA. M. (1951). Colorimetric estimation and histochemical demonstration of serum cholinesterase. Journal of Biological Chemistry, 191, 843–857.
94.
ReinholdS. G.TourignyL. G.YonanV. L. (1953). Measurement of serum cholinesterase activity by a photometric indicator method. American Journal of Clinical Pathology, 23, 645–653.
95.
SmithR. L.LowenthalH.LehmannH.RyanE. (1959). A simple colorimetric method for estimating serum pseudocholinesterase. Clinica Chimica Acta, 4, 384–390.
96.
StedmanE.StedmanE. (1931). Studies on the relationship between chemical constitution and physiological action, III. The inhibitory action of certain synthetic urethanes on the activity of liver esterase. Biochemical Journal, 25, 1147–1167.
97.
StedmanE.StedmanE.EassonL. H. (1932). Cholinesterase. An enzyme present in the blood serum of the horse. Biochemical Journal, 26, 2056–2066.
98.
SzaszG. (1968a). Comparison between thiocholinesters and o-nitrophenylbutyrate as substrates in the assay of serum cholinesterase. Clinica Chimica Acta, 14, 646–659.
99.
SzaszG. (1968b). Cholinesterase bestimmung im serum mit acetyl- und butyrylthiocholin als substrat. Clinica Chimica Acta, 19, 191–204.
100.
ThompsonJ. C.WhittakerM. (1966). A study of the pseudocholinesterase in 78 cases of apnoea following suxamethonium. Acta Genetica et Statistica Medica, 16, 209–222.
101.
UeteT.MiyamatoV.OhinshiM.ShimanoN. (1972). Spectrophotometric micromethod for measuring cholinesterase activity in serum and plasma. Clinical Chemistry, 18, 454–458.
102.
WhittakerM. (1968a). The cholinesterase variants: differentiation by means of sodium chloride. Acta Genetica et Statistica Medica, 18, 556–562.
103.
WhittakerM. (1968b). Differential inhibition of human serum cholinesterase with n-butyl alcohol: recognition of new phenotypes. Acta Genetica et Statistica Medica, 18, 335–340.
104.
WhittakerM.HardistyC. A. (1969). Properties of ‘usual’ and ‘atypical’ cholinesterases using o-nitrophenylbutyrate as substrate. Clinical Chemistry, 15, 445–451.
105.
WhittakerM.SpencerR.SearleJ. (1977). Plasma cholinesterase and malignant hyperthermia (Letter). British Journal of Anaesthesia, 49, 393.
106.
WhittakerM.VickersM. D. (1968). Suxamethonium apnoea (Letter). British Journal of Anaesthesia, 40, 393.
107.
WhittakerM.VickersM. D. (1970). Initial experiences with the Cholinesterase Research Unit. British Journal of Anaesthesia, 42, 1016–1020.
108.
ZellerE. A.BisseggerA. (1943). Über die Cholinesterase des Gehirns und der Erythrocyten. Helvetia Chimica Acta, 26, 1619–1630.